U.S., Jan. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06790498) titled 'Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product' on Jan. 14.
Brief Summary: The purpose of this study is to evaluate the long-term safety, efficacy, and durability in participants with chronic kidney disease (CKD) who received up to four REACT injections, delivered percutaneously into either the same or bilateral kidneys in previous studies.
Study Start Date: Nov. 23, 2023
Study Type: OBSERVATIONAL
Condition:
Diabetic Kidney Disease
Chronic Kidney Disease
Intervention:
BIOLOGICAL: Renal Autologous Cell Therapy (REACT)
No interventions in this trial
Recruitment Status: ENROLLI...